NucleoSpin Dx Virus

Additional information

Brand

Size

50 Preps

Applications

  • Isolation of viral RNA and / or viral DNA from 150 μL human plasma or serum* for subsequent in‑vitro diagnostic purposes
  • Isolation of viral RNA and / or viral DNA from animal samples, swabs, plasma, or serum (fresh or frozen, EDTA or citrate treated)**

Features

  • CE-IVD certification in compliance with EU directive 98/79/EC for in‑vitro diagnostic applications*
  • Sensitive detection of DNA / RNA viruses from fresh / frozen serum / plasma treated with EDTA / citrate

Specifications

  • Technology: Silica membrane technology
  • Sample material: Plasma / serum (150 μL)
  • Fragment size: 100 bp–approx. 50 kbp
  • Elution volume: 50 μL
  • Binding capacity: 40 μg
  • Processing time: 30 min/6 preps

CE-marked procedure – sensitive viral DNA and RNA detection

Detection of viral RNA and DNA in Real-time PCR (Artus RealArt™ HCV RNA / HBV DNA; Roche LightCycler® 480), purified by NucleoSpin® Dx Virus. Nucleic acids were purified from virus samples of different titers and used for quantification. A) Detection of RNA from HCV samples of different titers. B) Detection of DNA from HBV samples of different titers.

Data was generated by Dr. Tiemann, LABCON-OWL GmbH, Germany.

Guery B, et. al. Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission. Lancet 2013 Jun; 381 (9885): 2265-72

Nucleic acid extraction for in-vitro diagnostics Brochure